Chris Markoch

Chris Markoch

InvestorPlace Contributor

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

It’s Time to Give Up on Occidental Petroleum

By Chris Markoch, InvestorPlace Contributor

Traders seemed to disregard the problems surrounding OXY stock as oil prices were rising. But with demand set to fall, get serious.

Carnival’s Fortunes Are Pinned to the Recovery, Not the Virus

By Chris Markoch, InvestorPlace Contributor

Although health concerns cast a dark cloud on CCL stock, it's the economy that will have the final say on its trajectory.

Remark Holdings’ Impressive Run Won’t Last

By Chris Markoch, InvestorPlace Contributor

MARK stock is having an impressive run as of late. However, optimism in the stock seems based on a future that may not happen.

5 Music Stocks to Help Your Portfolio Groove

By Chris Markoch, InvestorPlace Contributor

With attention on streaming video, investors may think there's no growth potential in music stocks. Here's why that's a bad assumption.

The Very Simple Case For (or Against) Penn Nation Gaming

By Chris Markoch, InvestorPlace Contributor

PENN stock is near its all-time high as investors bet on revenue from sports betting. But with surging virus cases, that revenue is still in question.

Don’t Be the Greater Fool with Nikola Stock

By Chris Markoch, InvestorPlace Contributor

On paper, Nikola stock looks like a promising bet. But the core fundamentals are also on paper, posing technical worries for NKLA.

The Curtain Is Coming Down on IBIO

By Chris Markoch, InvestorPlace Contributor

It appears iBio may have to settle for an assist in the race for a Covid-19 vaccine, but that gives investors little reason to buy IBIO stock.

3 Reasons Why JetBlue Is a Good Post-Pandemic Bet

By Chris Markoch, InvestorPlace Contributor

Although the current headlines don't look great for the airliner industry, JBLU stock is surprisingly well positioned for the post-pandemic future.

7 Healthcare ETFs Which Should Continue Growing Into 2021

By Chris Markoch, InvestorPlace Contributor

Between the novel coronavirus and an election year, these healthcare ETFs appear poised to post strong growth into 2021.

Microchip Technology Is Predictable and That’s Not Bad

By Chris Markoch, InvestorPlace Contributor

MCHP stock won't grab headlines. However, it will provide investors with reliable gains, either actively or passively, and that's a win in this economy.

Load More